| Literature DB >> 23940684 |
Mignon A Keaton1, Roberto R Rosato, Konrad B Plata, Christopher R Singh, Adriana E Rosato.
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as one of the most important pathogens both in health care and community-onset infections. The prerequisite for methicillin resistance is mecA, which encodes a β-lactam-insensitive penicillin binding protein PBP2a. A characteristic of MRSA strains from hospital and community associated infections is their heterogeneous expression of resistance to β-lactam (HeR) in which only a small portion (≤ 0.1%) of the population expresses resistance to oxacillin (OXA) ≥ 10 µg/ml, while in other isolates, most of the population expresses resistance to a high level (homotypic resistance, HoR). The mechanism associated with heterogeneous expression requires both increase expression of mecA and a mutational event that involved the triggering of a β-lactam-mediated SOS response and related lexA and recA genes. In the present study we investigated the cellular physiology of HeR-MRSA strains during the process of β-lactam-mediated HeR/HoR selection at sub-inhibitory concentrations by using a combinatorial approach of microarray analyses and global biochemical profiling employing gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS) to investigate changes in metabolic pathways and the metabolome associated with β-lactam-mediated HeR/HoR selection in clinically relevant heterogeneous MRSA. We found unique features present in the oxacillin-selected SA13011-HoR derivative when compared to the corresponding SA13011-HeR parental strain that included significant increases in tricarboxyl citric acid (TCA) cycle intermediates and a concomitant decrease in fermentative pathways. Inactivation of the TCA cycle enzyme cis-aconitase gene in the SA13011-HeR strain abolished β-lactam-mediated HeR/HoR selection demonstrating the significance of altered TCA cycle activity during the HeR/HoR selection. These results provide evidence of both the metabolic cost and the adaptation that HeR-MRSA clinical strains undergo when exposed to β-lactam pressure, indicating that the energy production is redirected to supply the cell wall synthesis/metabolism, which in turn contributes to the survival response in the presence of β-lactam antibiotics.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23940684 PMCID: PMC3733780 DOI: 10.1371/journal.pone.0071025
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Differential gene expression analysis of metabolism-related pathways between strains SA13011-HoR vs. SA13011-HeR.
| ORF | Gene | Fold change | Name | Description | |
|
| |||||
|
|
| 3.7 | ribokinase | Catalyses the phosphorylation of ribose to ribose-5-P | |
|
|
| 5.3 | D-ribose pyranase | Catalyzes the conversion between beta-pyran and beta-furan forms of D-ribose. | |
|
|
| 4.2 | hypothetical protein | Putative ribose uptake protein rbsU. | |
|
|
| 3.5 | Ribulokinase | Catalyzes the phosphorylation of ribulose to ribulose-5-P | |
|
|
| 4.8 | glycerol uptake facilitator | Facilitates diffusion of glycerol into the cells. | |
|
| −23.1 | alpha-glucosidase | Converts trehalose-6-P into D-glucose 6-P. | ||
|
| −11.2 | sugar-specific PTS transport system, IIBC component | Phosphotransferase transport system (PTS), | ||
|
| −19.8 | putative glycosyl hydrolase | Converts trehalose-6-P into glucose-6-P. | ||
|
|
| 5.2 | mannitol-1-phosphate 5-dehydrogenase | Catalyzes: D-mannitol-1-P+NAD+ = D-fructose-6-P+NADH | |
|
| 2 | glucose-6-phosphate 1-dehydrogenase | Catalyzes: D-glucose-6-P+NADP+ = D-glucono-1,5-lactone-6-P+NADPH | ||
|
|
| 2.3 | hypothetical protein | pentose phosphate pathway | |
|
|
|
| hypothetical protein | Transports L-lactate across the membrane. | |
|
|
| hypothetical protein | homolog of L-lactate permease lctP | ||
|
|
| hypothetical protein | Maltose/maltodextrin transport permease | ||
|
| 2.9 | glucose-specific PTS transporter protein, IIABC component | Phosphotransferase transport system (PTS), glucose-specific. | ||
|
| −5.5 | putative PTS transport system, IIABC component | Putative phosphotransferase transport system (PTS), mannose specific. | ||
|
| 8.9 | hypothetical protein | Phosphotransferase transport system (PTS) | ||
|
|
| −4.6 | PTS system glucose-specific EIICBA component | Phosphotransferase transport system (PTS, glucose-specific). | |
|
| 4.2 | PTS system EIIBC component | Putative phosphotransferase transport system (PTS), EIIBC component. | ||
|
|
| −4 | PTS system glucoside-specific IICBA component | Phosphotransferase transport system (PTS), glucoside specific. | |
|
|
| −2.7 | glycerol-3-phosphate transporter | Transport of glycerol-3-P. | |
|
|
| −3.1 | acetate/propionate kinase | Involved in pyruvate, propanoate, taurine and hypotaurine metabolism (conversion of acetate to acetyl-P and propanoate into propanoyl-P) | |
|
|
| 3.1 | acylphospha-tase | Involved in pyruvate metabolism, glycolysis/gluconeogenesis. | |
|
|
| 4 | acetyl-coenzyme A synthetase | Conversion of acetate and CoA to acetyl-CoA. | |
|
|
| 5.6 | Phosphoenol-pyruvate carboxykinase | Involved in the TCA cycle and pyruvate metabolism (catalyzesATP+oxaloacetate = ADP+phosphoenolpyruvate+CO2) | |
|
|
| 6.3 | aconitate hydratase | Involved in the TCA cycle (conversion of citrate to isocitrate). | |
|
|
| 2.2 | Dihydrolipo-amide acetyltrans-ferase | Involved in the TCA cycle and lysine degradation. | |
|
|
| 8.9 | citrate synthase | Catalyzes the first step in the TCA cycle. | |
|
|
| 11 | isocitrate dehydro-genase | Involved in the TCA cycle (converts isocitrate to alpha ketoglutarate). | |
|
|
| 2.5 | fumarate hydratase, class-II | Involved in the TCA cycle (converts (S)-malate to fumarate and water). | |
|
|
| 3.3 | succinyl-CoA synthetase alpha subunit | Catalyzes the only substrate-level phosphorylation in the TCA cycle. | |
|
|
| −3 | pyruvate carboxylase | Involved in the TCA cycle, alanine and aspartate metabolism, pyruvate metabolism. | |
|
|
| 4.8 | glyceraldehyde 3-phosphate dehydrogenase | Involved in glycolysis and glyconeogenesis. | |
|
| −2.2 | hypothetical protein similar to fructokinase | Catalyzes conversion of fructose to fructose-6-P | ||
|
| |||||
|
|
| −2.3 | fructose-bisphosphate aldolase | Involved in gluconeogenesis | |
|
|
| −4 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase | Involved in glycolysis/gluconeogenesis | |
|
| 2.9 | hypothetical protein | Putative fructose-1,6-bisphosphatase III involved in glycolysis/gluconeogenesis, pentose phosphate pathway and fructose and mannose metabolism | ||
|
| −3.1 | hypothetical protein | Similar to sugar phosphate isomerases/epimerases | ||
|
| −4 | hypothetical protein | Putative formate dehydrogenase | ||
|
|
| 2.4 | NADPH-dependent oxidoreductase | Involved in maintenance of the cellular redox state and the disulfide stress response | |
|
|
| −10.8 | D-lactate dehydroge-nase | Catalyzes the formation of pyruvate from lactate | |
|
|
| −10.5 | formate acetyltrans-ferase | Catalyzes a key step in anaerobic glycolysis (conversion of pyruvate and CoA to formateacetyl-CoA) | |
|
|
| −5.7 | L-lactate dehydro-genase | Catalyzes conversion of pyruvate (the final product of glycolysis) to lactate in the absence of oxygen | |
|
| |||||
|
|
| −4.8 | probable quinol oxidase subunit 4 | Involved in oxidative phosphorylation pathway. | |
|
|
| −2.7 | putative manganese-dependent inorganic pyrophosphatase | Involved in oxidative phosphorylation pathway, catalyzes the hydrolysis of pyrophosphate to phosphate. | |
|
|
| −3.5 | cytochrome oxidase assembly protein | Cytochrome oxidase assembly protein. | |
|
| −4.8 | hypothetical protein | Similar to transmembrane efflux pump protein. | ||
|
| |||||
|
|
| 3.3 | alanine dehydrogenase | Role in cell wall synthesis, as L-alanine is an important constituent of the peptidoglycan layer. | |
|
|
| 2.9 | glycine dehydrogenase subunit 2 | Catalyzes the degradation of glycine. | |
|
|
| 4.8 | glycine dehydrogenase subunit 1 | Glycine cleavage system P-protein subunit 1. | |
|
|
| 5.3 | aminomethyltransferase | Glycine cleavage system aminomethyltransferase T. | |
|
| 7.2 | hypothetical protein | Similar to D-serine/D-alanine/glycine transporter. | ||
|
| −5.9 | pyruvate oxidase | Similar to pyruvate oxidase (catalyzes formation of acetyl phosphate from pyruvate). | ||
|
| 8.4 | hypothetical protein | Similar to L-serine dehydratase (catalyses deamination of serine to form pyruvate). | ||
|
|
| 4.2 | ornithine-oxo-acid transaminase | Involved in urea cycle and metabolism of amino groups. | |
|
|
| 4.8 | 1-pyrroline-5-carboxylate dehydrogenase | Involved in L-proline degradation into L-glutamate | |
|
| 3 | hypothetical protein | Similar to proline dehydrogenase. | ||
|
| 8.2 | hypothetical protein | Similar to allophanate hydrolase subunit 2 | ||
|
| 3 | hypothetical protein | Predicted glutamine amidotransferase | ||
|
| 2 | hypothetical protein | acetyltransferase (isoleucine patch superfamily) | ||
|
| −2.2 | hypothetical protein | Similar to amino acid transporters | ||
|
| −2.3 | hypothetical protein | Similar to branched-chain amino acid transport system carrier protein. | ||
|
|
| −2.9 | oligopeptide transporter putative membrane permease domain | dipeptide/oligopeptide/nickel transport systems. | |
|
| −2.4 | hypothetical protein | Similar to ABC transporter | ||
|
| 7.6 | hypothetical protein | Similar to gamma-aminobutyrate permease and related permeases. | ||
|
| −2.3 | gamma-aminobutyrate permease | Amino acid transporter. | ||
|
|
| −2.6 | high affinity proline permease | Proline permease | |
|
| 3 | hypothetical protein | Similar to oligoendopeptidase F. | ||
|
| |||||
|
| 2.3 | hypothetical protein | Similar to tripeptidase | ||
|
|
| 2.6 | penicillin binding protein 2 | Membrane carboxypeptidase | |
|
|
| 2.8 | penicillin binding protein 2A | Membrane transpeptidase | |
|
|
| 3.0 | factor essential for expression of methicillin resistance | Factor essential for expression of methicillin resistance; involved in the formation of the staphylococcal pentaglycine interpeptide bridge | |
|
|
| 5.0 | putative glycosyl/glycerophos-phate transferase | Similar to teichoic acid biosynthesis protein F (TagF) | |
|
|
| 5.3 | D-fructose-6-phosphate amidotransferase | Catalyzes the first step in hexosamine metabolism (converts fructose-6P into glucosamine-6P) | |
|
| 3.0 | putative cell shape determinant mreC | Rod shape-determining protein | ||
|
|
| 3.0 | undecaprenyl pyrophosphate phosphatase | Participates in peptidoglycan biosynthesis; involved in bacitracin resistance | |
|
| 2.8 | N-acetylmuramoyl-L-alanine amidase precursor | Autolysin precursor | ||
|
|
| 7.9 | N-acetylmuramic acid 6-phosphate etherase | Involved in N-acetylmuramic acid degradation | |
|
|
| −2.7 | glycine betaine transporter | Transporter | |
|
| −6.4 | hypothetical protein | Probable glycine betaine transporter opuD homolog. | ||
|
| −3.6 | hypothetical protein | Similar to CsbB stress response protein. | ||
|
| −2.2 | hypothetical protein | Similar to nucleoside-diphosphate-sugar epimerases. | ||
|
|
| 7.2 | glycerol kinase | Involved in the regulation of glycerol uptake and metabolism, glycerolipid metabolism (catalyzes glycerol to glycerol 3-P). | |
|
|
| −13.4 | PTS enzyme II, phosphoenol-pyruvate-dependent, trehalose-specific | Phosphotransferase transport system (PTS), trehalose-specific. | |
Figure 1Quantitation of mRNA levels of TCA cycle-, amino-acid catabolism-, carbohydrate catabolism- and cell wall-associated genes by real-time RT-PCR.
RNA was prepared from SA13011-HeR and its highly resistant derivative SA13011-HoR (SA13011+ OXA 0.5 µg/ml) cells, collected at exponential phase of growth, as described in Materials and Methods. Relative fold change values of specific mRNAs in SA13011-HoR vs. SA13011-HeR (reference value = 1) are shown on the vertical axis. Relative fold change values representing the means of at least three biological replicates of specific mRNAs ± standard error of the mean (SEM), sampled in triplicate to minimize error by inter- and intra-samples, are shown on the vertical axis; 16S rRNA was used as an internal control. Differences between the mean values were analyzed using a one-way analysis of variance (ANOVA). A P value of <0.01 was considered statistically significant. Oligonucleotide primers are shown in Table S2.
Summary showing the number of biochemicals statistically significantly different (p<0.05) between SA13011-HoR vs. SA13011-HeR.
| Welch's Two Sample t-Tests | Number of biochemicals with p≤0.05 | Number of biochemicals increased p≤0.05 | Number of biochemicals decreased p≤0.05 |
|
| 98 | 15 | 83 |
Figure 2Heat map of metabolite levels profiled in the heterogeneous SA13011 strain (HeR) and its highly homogeneous methicillin resistant derivative SA13011-HoR (SA13011+ OXA 0.5 µg/ml).
Red indicates high levels and green indicates low levels of each biochemical arranged on they-axis.
Figure 3Analysis of biochemicals associated with the TCA cycle determined by global biochemical profiling across SA13011-HeR and SA13011-HoR (SA13011+ OXA 0.5 µg/ml) derivative.
Figure 4Analysis of biochemicals associated with sources of acetyl-CoA generation from β-oxidation of fatty acids in SA13011-HeR and SA13011-HoR (SA13011+ OXA 0.5 µg/ml) during β-lactam mediated HeR/HoR selection.
Figure 5Analysis of biochemicals corresponding to energy metabolism components NADH, NAD+, FAD, phosphate and pyrophosphate (PPi) levels during β-lactam mediated SA13011-HeR/HoR selection.
Figure 6Schematic representation of genes and/or metabolites related to the TCA cycle summarizing changes in both mRNA expression and biochemical levels.
Red coloration represents up-regulation while green coloration represents down-regulation during β-lactam mediated HeR/HoR selection.
Strains and plasmids used in this study.
| Strain | Relevant Genotype and phenotype | Reference or Source |
| SA13011-HeR | Heterogeneous [ |
|
| SA13011-HoR | SA13011-HeR+OXA (0.5 |
|
| LMR15 | SA13011-HeR Δ | This study |
| LMR16 | LMR-15+ OXA (0.5 µg/ml); LMR-15 homogeneous derivative | This study |
| LMR17 | LMR15+ wild type | This study |
| LMR18 | LMR-17+ OXA (0.5 µg/ml); LMR-17 homogeneous derivative | This study |
| RN4220 | Restriction deficient Mutagenized RN450 |
|
| SA564 Δ |
|
|
|
| ||
|
| Ampr Kanr | Invitrogen |
|
| High-copy staphylococcal replicon |
|
+OXA: indicates the corresponding resistant derivative strain was obtained by growing in the presence of the indicated sub-inhibitory concentrations of OXA.
Figure 7Quantitation of acnA mRNA (A) and TCA cycle-associated genes (B) by Real-Time RT-PCR.
RNAs were prepared from SA13011-HeR/HoR, acnA-null mutant LMR15 and LMR15 complemented with either the empty-vector (LMR15-EV) or wild-type acnA (LMR17), grown in the absence or presence of OXA (0.5 µg/ml). Cells were collected at exponential phase of growth as described in Materials and Methods. Relative fold change values versus SA13011-HeR ( = 1) of specific mRNAs are shown in the vertical axis; 16rRNA was used as an internal control. *, significantly different than SA13011-HeR (P<0.001).h.
MICs to oxacillin (OXA) corresponding to S. aureus aconitase mutants.
| STRAIN | MIC OXA (µg/ml) |
| SA13011-HeR | 2 |
| SA13011-HoR (SA13011-HeR+OXA 0.5 µg/ml); SA13011 homogeneous derivative |
|
| LMR15 (SA13011 ΔacnA::tetM) | 1 |
| LMR-16 (LMR-15+ OXA 0.5 µg/ml); LMR-15 homogeneous derivative | 0.75 |
| LMR17 (LMR15+ wild type acnA) | 1 |
| LMR18 (LMR17+ OXA 0.5 µg/ml); LMR-17 homogeneous derivative |
|
| LMR15+ EV | 0.5 |
| LMR15+ EV+OXA (0.5 µg/ml) | 1 |
| SA13011-HeR+glu | 1 |
| SA13011-HeR+OXA (0.5 µg/ml)+glu |
|
| LMR17+ OXA (0.5 µg/ml)+glu |
|
| LMR15+ EV+OXA (0.5 µg/ml)+glu | 1 |
Figure 8Susceptibility testing of SA13011 aconitase mutant LMR15 and derivatives (−/+ OXA 05 µg/ml; Table 4).
Overnight inoculum was diluted to 0.5 Mc Farland standard and swabbed onto MH agar. glu: cells were grown in media supplemented with glucose 10mM. E-test strips were placed on the plates and incubated at 37°C for 24 h. A representative picture of repeated (3) experiments is shown.